Claudia PARISI, MD
@PARISImd
Followers
387
Following
580
Statuses
127
Medical Oncologist & PhD student | Passionate about lung cancer, genomics, investigational cancer therapeutics
Institut Gustave Roussy (IGR)
Joined January 2022
We shed 💡 on NEOADJUVANT ICBs strategies for resectable NSCLC among special populations🧬👩🦰 👵🏻 @PamelaAbdayem @M_Tagliamento @JordiRemon @BenjaminBesseMD @dplanchard @FedericoCappuz1 @barlesi Just out on Cancer Treatment Reviews
0
4
20
0
0
1
0
0
0
RT @DrYukselUrun: Congratulations to Fabrice André on becoming ESMO President 2025-2026 and to the entire ESMO leadership team! @FAndreMD @…
0
16
0
RT @doctordegio: STK11 mutations show a clear link with worse overall survival (OS), irrespective of treatment modality or co-mutations (KR…
0
3
0
ToxicitéGenrePoumon - SNDS We focus on sex/gender related differences in tolerability with novel targeted therapies. Next step include assessing digital health preferences in remote monitoring @barlesi @MaximilienAuth1 @Resiliencecare @GustaveRoussy
0
1
4
RT @LodovicaZullo: New one from our MTB showing the caveats of the "new era" in oncogene+NSCLC: overcoming complex/multiple bypass resistan…
0
4
0
RT @GustaveRoussy: 🫁 Novembre #thoracique à @GustaveRoussy 🫁 ✅ Vous avez plus de 40 ans ? ✅ Vous fumez ou avez fumé ? Suivez le lien ci-c…
0
5
0
RT @caliraf: We have a position available from Jan/Feb 2025. Fantastic opportunity to join the Lung Team @TheChristieNHS as Clinical Resear…
0
21
0
We shed 💡 on NEOADJUVANT ICBs strategies for resectable NSCLC among special populations🧬👩🦰 👵🏻 @GustaveRoussy Just out on Cancer Treatment Reviews
0
0
3
Exploring the Role of Target Expression in Treatment Efficacy of Antibody-Drug Conjugates (ADCs) in Solid Cancers: … Read this review by @LtMathiot @KaissaOuali et al. to know more on target protein dynamics of ADC-based cancer therapies @GustaveRoussy
0
0
3
Proud of my friend and colleague @DiFedericoMD
Just published in @Annals_Oncology our study investigating intrapatient variation in PD-L1 & TMB and the impact on outcomes to #immunotherapy in patients with #NSCLC 🧵1/9 @DanaFarberNews @DFarberThoracic @myESMO @IASLC @OncoAlert @OncLive #LCSM
1
1
3
@DiFedericoMD @Annals_Oncology @DanaFarberNews @DFarberThoracic @myESMO @IASLC @OncoAlert @OncLive Sei GRANDE!!!!! 🙌
0
0
1
Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): a monocentric experience - The Journal of Liquid Biopsy
0
3
19
RT @dplanchard: Now it's your turn, and registration is open for this @myESMO Presceptorship lung in Paris in November, with a superb progr…
0
6
0
DU Coordination et Santé Connecté 2024 - présentation du circuit de la RCP moléculaire de @GustaveRoussy avec Laetitia Millier. Merci à tout l’équipe medicine de précision de IGR, les équipes Onco med et notre immense unité essai précoce @drcmassard 🧬
0
0
3
RT @jitcancer: New #JITC commentary: Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced s…
0
1
0